REGENERATIVE MEDICAL TECHNOLOGY GROUP INC. (MSSV) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
433 PLAZA REAL SUITE 275 BOCA RATON, FL 33432 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 599 - Retail Stores, Not Elsewhere Classified (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 531 | 2,979 | 43 | 23 | 31 | ||||
| Cash and cash equivalents | 531 | 2,979 | 43 | 23 | 31 | ||||
| Restricted cash and investments | 23 | 31 | |||||||
| Receivables | 24 | 50 | 17 | ||||||
| Inventory, net of allowances, customer advances and progress billings | |||||||||
| Inventory | |||||||||
| Prepaid expense | 21 | 24 | |||||||
| Deferred costs | 49 | ||||||||
| Other undisclosed current assets | 1,596 | 0 | (23) | (31) | |||||
| Total current assets: | 575 | 1,695 | 3,020 | 43 | 23 | 31 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 3 | 34 | ✕ | ||||||
| Property, plant and equipment | 359 | 186 | 23 | 2 | 3 | 4 | |||
| Intangible assets, net (including goodwill) | 1,937 | 6,160 | 6,257 | ||||||
| Goodwill | 1,680 | 5,805 | 5,805 | ||||||
| Intangible assets, net (excluding goodwill) | 257 | 354 | 452 | ||||||
| Other noncurrent assets | 6 | ||||||||
| Other undisclosed noncurrent assets | 6 | 6 | 175 | ||||||
| Total noncurrent assets: | 2,304 | 6,385 | 6,286 | 177 | 3 | 4 | |||
| TOTAL ASSETS: | 2,879 | 8,080 | 9,306 | 220 | 26 | 35 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 7,019 | 4,903 | 4,258 | 376 | 423 | 385 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 1,878 | 62 | ||||
| Accounts payable | 421 | 245 | 251 | ||||||
| Accrued liabilities | 6,597 | 4,658 | 2,129 | 437 | |||||
| Other undisclosed accounts payable and accrued liabilities | 314 | 423 | (53) | ||||||
| Deferred revenue | ✕ | ||||||||
| Debt | 15,224 | 7,047 | 1,528 | 163 | 1,275 | 813 | |||
| Derivative instruments and hedges, liabilities | 4,731 | 2,938 | |||||||
| Other liabilities | 20 | ||||||||
| Due to related parties | ✕ | ✕ | 252 | ||||||
| Other undisclosed current liabilities | 7 | 50 | (1,840) | 376 | 537 | 437 | |||
| Total current liabilities: | 22,249 | 12,000 | 4,218 | 914 | 6,966 | 4,573 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 8,016 | 34 | 14 | 0 | |||||
| Long-term debt, excluding current maturities | 8,016 | 34 | 14 | 0 | |||||
| Liabilities, other than long-term debt | 8 | 8 | 8 | 8 | |||||
| Due to related parties | ✕ | ✕ | 8 | 8 | 8 | ||||
| Operating lease, liability | 1 | ✕ | |||||||
| Derivative instruments and hedges, liabilities | 7 | ||||||||
| Other undisclosed noncurrent liabilities | 2,425 | 38 | 11,803 | 5,609 | 324 | ||||
| Total noncurrent liabilities: | 2,425 | 8,063 | 11,845 | 5,631 | 332 | ||||
| Total liabilities: | 24,675 | 20,063 | 16,063 | 6,546 | 7,299 | 4,573 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (21,796) | (11,982) | (6,757) | (6,410) | (7,356) | (4,539) | |||
| Preferred stock | 1 | 0 | |||||||
| Common stock | 12 | 12 | 12 | 11 | 8 | 5 | |||
| Additional paid in capital | 40,181 | 40,181 | 39,899 | 27,364 | 20,524 | 20,835 | |||
| Accumulated deficit | (61,990) | (52,176) | (46,670) | (33,785) | (27,889) | (25,380) | |||
| Other undisclosed equity, attributable to parent | 1 | 0 | 1 | 0 | 1 | 1 | |||
| Other undisclosed equity | 0 | 0 | 84 | ||||||
| Total equity: | (21,796) | (11,982) | (6,757) | (6,326) | (7,356) | (4,539) | |||
| Other undisclosed liabilities and equity | (0) | 84 | |||||||
| TOTAL LIABILITIES AND EQUITY: | 2,879 | 8,080 | 9,306 | 220 | 26 | 35 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,410 | 1,530 | 475 | 55 | 30 | 50 | ||
| Revenue from related parties | ✕ | ✕ | 330 | |||||
| Cost of revenue | (734) | (653) | (330) | (44) | (56) | (15) | ||
| Other undisclosed gross profit | ||||||||
| Gross profit: | 1,676 | 877 | 145 | 11 | (25) | 35 | ||
| Operating expenses | (2,391) | (2,062) | (10,078) | (460) | (1,566) | (290) | ||
| Other operating expense, net (Other Expenses) | (504) | (504) | ||||||
| Operating loss: | (715) | (1,688) | (10,436) | (448) | (1,591) | (255) | ||
| Nonoperating income (expense) | (6,489) | (4,390) | 878 | |||||
| Investment income, nonoperating | (6,492) | 13 | 878 | |||||
| Other nonoperating income (expense) | 2 | (4,404) | ||||||
| Interest and debt expense | 1,511 | (2,724) | (4,204) | (584) | (528) | |||
| Loss from continuing operations before income taxes: | (5,693) | (6,079) | (12,282) | (4,653) | (2,175) | (784) | ||
| Income tax benefit | 1,156 | 2,706 | ||||||
| Loss from continuing operations: | (5,693) | (4,922) | (9,577) | (4,653) | (2,175) | (784) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (9,577) | (4,653) | (2,175) | (784) | |
| Income from discontinued operations | 68 | |||||||
| Other undisclosed net income (loss) | (653) | (3,308) | (1,243) | (334) | ||||
| Net income (loss): | (5,693) | (5,507) | (12,884) | (5,896) | (2,509) | (784) | ||
| Other undisclosed net loss attributable to parent | (4,121) | (1,274) | ||||||
| Net loss available to common stockholders, diluted: | (9,814) | (5,507) | (12,884) | (5,896) | (2,509) | (2,058) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (5,693) | (5,507) | (12,884) | (5,896) | (2,509) | (784) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (5,693) | (5,507) | (12,884) | (5,896) | (2,509) | (784) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.